Health and Fitness Health and Fitness
Tue, October 25, 2011
Mon, October 24, 2011
[ Mon, Oct 24th 2011 ] - Market Wire
Cigna to Acquire HealthSpring
Sat, October 22, 2011
Fri, October 21, 2011
Thu, October 20, 2011
Wed, October 19, 2011
Tue, October 18, 2011
Mon, October 17, 2011
Sun, October 16, 2011
Sat, October 15, 2011
Fri, October 14, 2011
Thu, October 13, 2011
Wed, October 12, 2011
[ Wed, Oct 12th 2011 ] - Market Wire
Financial Statement 10/11
Tue, October 11, 2011
[ Tue, Oct 11th 2011 ] - Market Wire
Aetna??Michael Elliott???????
Mon, October 10, 2011

Los datos sobre el uso temprano y los beneficios a largo plazo de TYSABRI han sido presentados en el 5 congreso trienal conjun


//health-fitness.news-articles.net/content/2011/ .. presentados-en-el-5-congreso-trienal-conjun.html
Published in Health and Fitness on Wednesday, October 19th 2011 at 7:46 GMT by Market Wire   Print publication without navigation


WESTON, Massachussets & DUBLIN--([ BUSINESS WIRE ])--[ Biogen Idec ] (NASDAQ: BIIB) y [ Elan Corporation, plc ](NYSE: ELN) han anunciado las 28 presentaciones de la empresa sobre TYSABRI? (natalizumab) durante el 5? congreso trienal conjunto de los comit?s europeos y americanos para el tratamiento e investigaci?n de la esclerosis m?ltiple (ECTRIMS y ACTRIMS), celebrado en ?msterdam (Holanda).

El comunicado en el idioma original, es la versi?n oficial y autorizada del mismo. La traducci?n es solamente un medio de ayuda y?deber? ser?comparada con el texto en idioma original, que es la ?nica versi?n del texto que tendr? validez legal.


Publication Contributing Sources